[
    {
        "title": "What Makes AcelRx Pharmaceuticals (ACRX) a New Buy Stock - Yahoo Finance",
        "description": "What Makes AcelRx Pharmaceuticals (ACRX) a New Buy Stock  Yahoo Finance",
        "published date": "Tue, 22 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tYWtlcy1hY2VscngtcGhhcm1hY2V1dGljYWxzLWFjcngtYnV5LTIxMzAzNDEzMy5odG1s0gFbaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvbWFrZXMtYWNlbHJ4LXBoYXJtYWNldXRpY2Fscy1hY3J4LWJ1eS0yMTMwMzQxMzMuaHRtbA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "AcelRx Pharmaceuticals (ACRX) Reports Break-Even Earnings for Q1 - Yahoo Finance",
        "description": "AcelRx Pharmaceuticals (ACRX) Reports Break-Even Earnings for Q1  Yahoo Finance",
        "published date": "Wed, 10 May 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hY2VscngtcGhhcm1hY2V1dGljYWxzLWFjcngtcmVwb3J0cy1icmVhay0yMjI1MTAxNTEuaHRtbNIBX2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2FjZWxyeC1waGFybWFjZXV0aWNhbHMtYWNyeC1yZXBvcnRzLWJyZWFrLTIyMjUxMDE1MS5odG1s?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "Why Galecto Shares Are Trading Higher By Around 30%; Here Are ... - Benzinga",
        "description": "Why Galecto Shares Are Trading Higher By Around 30%; Here Are ...  Benzinga",
        "published date": "Wed, 27 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5iZW56aW5nYS5jb20vbmV3cy8yMy8wOS8zNDk0NTU0OS93aHktZ2FsZWN0by1zaGFyZXMtYXJlLXRyYWRpbmctaGlnaGVyLWJ5LWFyb3VuZC0zMC1oZXJlLWFyZS0yMC1zdG9ja3MtbW92aW5nLXByZW1hcmtldNIBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.benzinga.com",
            "title": "Benzinga"
        }
    },
    {
        "title": "AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q2 2023 Earnings Call Transcript - Yahoo Finance",
        "description": "AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q2 2023 Earnings Call Transcript  Yahoo Finance",
        "published date": "Sun, 13 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hY2VscngtcGhhcm1hY2V1dGljYWxzLWluYy1uYXNkYXEtYWNyeC0wOTMzNDY4NzcuaHRtbNIBXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2FjZWxyeC1waGFybWFjZXV0aWNhbHMtaW5jLW5hc2RhcS1hY3J4LTA5MzM0Njg3Ny5odG1s?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules - Yahoo Finance",
        "description": "AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules  Yahoo Finance",
        "published date": "Tue, 18 Jul 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hY2VscngtcGhhcm1hY2V1dGljYWxzLWFubm91bmNlcy0xMC1taWxsaW9uLTEyMDAwMDg0Mi5odG1s0gFhaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvYWNlbHJ4LXBoYXJtYWNldXRpY2Fscy1hbm5vdW5jZXMtMTAtbWlsbGlvbi0xMjAwMDA4NDIuaHRtbA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "AcelRx Pharmaceuticals Announces Reverse Stock Split - PR Newswire",
        "description": "AcelRx Pharmaceuticals Announces Reverse Stock Split  PR Newswire",
        "published date": "Tue, 25 Oct 2022 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYWNlbHJ4LXBoYXJtYWNldXRpY2Fscy1hbm5vdW5jZXMtcmV2ZXJzZS1zdG9jay1zcGxpdC0zMDE2NTkxNzYuaHRtbNIBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.prnewswire.com",
            "title": "PR Newswire"
        }
    },
    {
        "title": "Insider Buying: CEO Vincent Angotti Acquires 10000 Shares of ... - GuruFocus.com",
        "description": "Insider Buying: CEO Vincent Angotti Acquires 10000 Shares of ...  GuruFocus.com",
        "published date": "Tue, 12 Sep 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3Lmd1cnVmb2N1cy5jb20vbmV3cy8yMDgzODUzL2luc2lkZXItYnV5aW5nLWNlby12aW5jZW50LWFuZ290dGktYWNxdWlyZXMtMTAwMDAtc2hhcmVzLW9mLWFjZWxyeC1waGFybWFjZXV0aWNhbHMtaW5j0gEA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.gurufocus.com",
            "title": "GuruFocus.com"
        }
    },
    {
        "title": "AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 ... - PR Newswire",
        "description": "AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 ...  PR Newswire",
        "published date": "Thu, 30 Mar 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiqAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FjZWxyeC1waGFybWFjZXV0aWNhbHMtcmVwb3J0cy1mdWxsLXllYXItYW5kLWZvdXJ0aC1xdWFydGVyLTIwMjItZmluYW5jaWFsLXJlc3VsdHMtYW5kLXByb3ZpZGVzLWNvcnBvcmF0ZS11cGRhdGUtMzAxNzg2MzExLmh0bWzSAQA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.prnewswire.com",
            "title": "PR Newswire"
        }
    },
    {
        "title": "Baidu To Rally Over 29%? Here Are 10 Other Analyst Forecasts For ... - Investing.com UK",
        "description": "Baidu To Rally Over 29%? Here Are 10 Other Analyst Forecasts For ...  Investing.com UK",
        "published date": "Mon, 25 Sep 2023 12:39:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vdWsuaW52ZXN0aW5nLmNvbS9uZXdzL3N0b2NrLW1hcmtldC1uZXdzL2JhaWR1LXRvLXJhbGx5LW92ZXItMjktaGVyZS1hcmUtMTAtb3RoZXItYW5hbHlzdC1mb3JlY2FzdHMtZm9yLW1vbmRheS0zMTY2NDY40gGJAWh0dHBzOi8vbS51ay5pbnZlc3RpbmcuY29tL25ld3Mvc3RvY2stbWFya2V0LW5ld3MvYmFpZHUtdG8tcmFsbHktb3Zlci0yOS1oZXJlLWFyZS0xMC1vdGhlci1hbmFseXN0LWZvcmVjYXN0cy1mb3ItbW9uZGF5LTMxNjY0Njg_YW1wTW9kZT0x?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://uk.investing.com",
            "title": "Investing.com UK"
        }
    },
    {
        "title": "AcelRx Pharmaceuticals Announces Closing of Previously ... - PR Newswire",
        "description": "AcelRx Pharmaceuticals Announces Closing of Previously ...  PR Newswire",
        "published date": "Fri, 21 Jul 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMisgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FjZWxyeC1waGFybWFjZXV0aWNhbHMtYW5ub3VuY2VzLWNsb3Npbmctb2YtcHJldmlvdXNseS1hbm5vdW5jZWQtcHJpdmF0ZS1wbGFjZW1lbnQtcHJpY2VkLWF0LXRoZS1tYXJrZXQtdW5kZXItbmFzZGFxLXJ1bGVzLTMwMTg4MjY0MC5odG1s0gEA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.prnewswire.com",
            "title": "PR Newswire"
        }
    }
]